Home/ Supplements/ Niacin/ Focus Factor F29 Extra Strength

Focus Factor F29 Extra Strength

product on market Liquid Focus Factor Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains B vitamins, including B6, B12, and niacin, which are supported by strong evidence for maintaining cognitive function and energy metabolism. However, the overall evidence coverage for this specific ingredient profile is very limited at 0.5%. The product maintains a high safety score of 100/100.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Focus Factor F29 Extra Strength
Open Full PDF View on NIH DSLD →
Details

Label Data

29.5 mL
Serving Size
1
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
5 Calorie(s)
30 mg (188% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
40 mg (2353% DV)
30.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
500 mcg (20833% DV)
208.3× RDA — above typical dose 139 studies (A:1, B:44)
Sodium
5 mg (1% DV)
F29 ES Performance Blend
2010 mg

Other Ingredients

Water, Purified Natural & Artificial Flavors Sucralose Sodium Benzoate Potassium Sorbate Calcium Disodium EDTA
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: For maximum energy, drink one entire bottle at once. For moderate energy, take one half bottle. Use or discard within 72 hours (3 days) after opening.

Warnings & Precautions

Caution: One 2 oz. bottle contains 200mg of caffeine. Persons sensitive to caffeine should take with caution. For individuals with a normal caffeine tolerance. Stop using if you experience nervousness, sleeplessness and occasional rapid heartbeat.

Do not take if you are pregnant or nursing, or under 18 years of age.

Do not take if you are pregnant or nursing, or under 18 years of age.

Formulation Notes

Focus + energy Mental performance Energy boost

Vitamins

Sugar Free

Additional Information

Synergy A consumer healthcare company

Refrigeration is not necessary.

Metadata

Product Details

UPC / SKU8 11909 03256 2
DSLD Entry Date2025-01-23
Product TypeOther Combinations
FormLiquid
DSLD ID321666
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.